T-Bank's recent capital injection by its shareholders, Arab Bank and BankMed, which increased its paid-in capital to TL 300 million demonstrates their continued commitment towards the Bank
In line with both the bank's growth strategy and Turkey's strong economic growth, T-Bank's shareholders, BankMed and Arab Bank, boosted the bank's capital by TL 130 million. T-Bank, a niche bank servicing the corporate and SME sectors, will continue focusing on growing its commercial portfolio in the years to come. The capital injection, which increased the paid-in capital to TL 300 million, was contributed equally by BankMed and Arab Bank PLC's sister company, Arab Bank (Switzerland).
Over the last four years, T-Bank's focus has concentrated on Corporate and SME banking. Regarding the capital increase, Dincer Alpman, the General Manager of T-Bank stated, "The capital injection is very timely and in line with our growth strategy". Alpman added, "After the new capital increase, BankMed will maintain its 50 percent shareholding while the remaining 50 percent will be split among Arab Bank PLC one of the original shareholders, and Arab Bank (Switzerland), the new shareholder, holding 28 percent and 22 percent respectively. After the capital increase, T-Bank's capital adequacy ratio will increase to approximately 20 percent".
According to Alpman's statement, T-Bank's assets have increased by 3.4 times from the end of 2006 up to June 2011. During the same period, shareholders' equity has increased by more than three times and deposits have quadrupled. T-Bank's banking business is conducted through its network of 27 branches, located across Turkey's industrial and financial centers.
-Ends-
© Press Release 2011
